Kelly Shi

Stock Analyst at Jefferies

(2.44)
# 2,540
Out of 5,044 analysts
32
Total ratings
43.33%
Success rate
3.88%
Average return

Stocks Rated by Kelly Shi

Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129$148
Current: $165.07
Upside: -10.34%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23$28
Current: $16.11
Upside: +73.81%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31$44
Current: $19.25
Upside: +128.57%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $8.79
Upside: +70.65%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11$52
Current: $19.46
Upside: +167.21%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18$14
Current: $4.57
Upside: +206.35%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13$19
Current: $24.99
Upside: -23.97%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174$196
Current: $205.31
Upside: -4.53%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $4.75
Upside: +342.11%
Initiates: Buy
Price Target: $37
Current: $13.77
Upside: +168.70%
Maintains: Buy
Price Target: $15$6
Current: $3.04
Upside: +97.37%
Maintains: Buy
Price Target: $35$46
Current: $68.00
Upside: -32.35%
Initiates: Buy
Price Target: $81
Current: $92.68
Upside: -12.60%
Initiates: Buy
Price Target: $35
Current: $19.80
Upside: +76.81%
Initiates: Buy
Price Target: $36
Current: $2.80
Upside: +1,185.71%
Initiates: Buy
Price Target: $16
Current: $10.00
Upside: +60.00%
Initiates: Buy
Price Target: $40
Current: $61.17
Upside: -34.61%
Initiates: Buy
Price Target: $20
Current: $12.51
Upside: +59.87%
Initiates: Buy
Price Target: $8
Current: $2.59
Upside: +208.88%
Initiates: Buy
Price Target: $27
Current: $0.86
Upside: +3,034.07%
Initiates: Buy
Price Target: $52
Current: $14.73
Upside: +253.02%
Initiates: Buy
Price Target: $27
Current: $1.58
Upside: +1,608.64%
Initiates: Buy
Price Target: $33
Current: $1.77
Upside: +1,764.41%